BioMerieux Etest Cefotaxime CT 256 In Vitro Diagnostic Recall
BioMerieux SA is recalling Etest Cefotaxime CT 256 in vitro diagnostic devices because quality control results were out of range, potentially causing false resistant strain results.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II and involves a risk of harm (false resistant strain results) without reported injuries or illnesses, meeting the criteria for a High severity score.
Plain-English summary
BioMerieux SA is recalling 674 units of Etest Cefotaxime CT 256 WW and Etest Cefotaxime CT 256 US in vitro diagnostic devices. The recall was initiated because quality control results were out of range, which resulted in false resistant strains.
The affected products were distributed worldwide, including nationwide in the United States to specific states and to numerous international countries. The recall is classified as Class II by the U.S. Food and Drug Administration.
Healthcare facilities and laboratories should stop using the affected Etest Cefotaxime CT 256 devices and contact BioMerieux SA for instructions on how to return or dispose of the products.
The recalled product
- Product
- Etest Cefotaxime CT 256 WW and Etest Cefotaxime CT 256 US. in vitro diagnostic.
- Manufacturer
- BioMerieux SA
- Affected units
- 674
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- 1002774320
- 1002377890
- 1002590470
- 1002775330
- 1002379610
Distribution
Related recalls
Same manufacturer · BioMerieux SA
See all →- HighMYLA Diagnostic System Software Versions Recalled for Risk of False Negatives
FDA (Devices) · 2021-10-20
- HighMYLA Laboratory Software: Potential Test Result Alteration from Software Anomaly
FDA (Devices) · 2021-08-18
- ModerateBioMerieux NucliSENS Magnetic Extraction Reagents Recalled Due to Temperature Exposure
FDA (Devices) · 2018-10-31
- ModerateBioMerieux Recalls VIDAS FSH Assay Kits Due to Calibration Issues
FDA (Devices) · 2018-07-04
- ModerateBioMérieux PREVI Color Gram Reagents Recalled Due to Temperature Excursion
FDA (Devices) · 2018-06-20
Same hazard · false positive
See all →- HighHealthmark ProChek-II Medical Tests Recalled for Expired Ingredient
FDA (Devices) · 2026-09-02
- HighAmyloid 1-42-N plasma calibrators recalled over falsely elevated results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma cartridges recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma calibrators recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighAmyloid 1-42-N plasma cartridges recalled over falsely elevated results
FDA (Devices) · 2026-02-11